Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer Patients

NCT00574353 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

RADIATION: Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission

Sponsor

Memorial Sloan Kettering Cancer Center